Achieve Better Outcomes
Blood volume measurement ends the debate by taking the guesswork out of determining a patient’s blood
volume status — significantly improving multiple measures of patient outcomes by enabling volume guided management.
Significantly Reduce Heart Failure Mortality & Readmissions
Propensity matched-control trial in community hospital | n = 245, Mixed HFpEF/HFrEF

(P<0.001)

(P<0.001)

(P<0.001)
Blood Volume Measurements Improved ICU Survival
Prospective randomized control trial in surgical ICU | n = 100, 70% Septic Shock/Sepsis/40% ARDS

(P=0.03)

(P=0.14)

36 Hour Earlier
Treatment Decision

44% Change in Treatment
Strategy Versus Standard Care
Excellent Value in Healthcare
Blood Volume-Guided Treatment Extremely Cost-Effective
Retrospective analysis in hospitalized heart failure patients | n = 245, Mixed HFpEF/HFrEF

Well above the 0.227 previously reported

Far below the ICER threshold of $50,000
Approved for Reimbursement

Where Blood Volume Measurement Makes an Impact

Feature Videos
In the Spotlight
Watch Daxor CEO, Michael Feldschuh, Discuss How BVA-100 Technology is Joining to Fight COVID-19







